Medidata Solutions and INC Research Reach One-Year ASPire to Win Milestone



    Medidata Rave's Ease of Deployment, Reliable Reporting Features and
User-Friendly Training Tools Help Enable Leading CRO to Grow Global Client
Base

    NEW YORK & RALEIGH, N.C., December 5 /CNW/ - Medidata Solutions, a global
provider of electronic clinical data capture (EDC), management and reporting
solutions, and INC Research, a therapeutically-focused contract research
organization (CRO) with a trusted process for delivering reliable results,
today announced their one-year ASPire to Win(TM) partnership milestone. In
addition to INC Research's experience offering eClinical solutions to its
customers, keys to the success of this partnership include Medidata Rave's
fast and easy deployment capabilities, robust reporting tools and ability to
handle any size global study.

    Since November 2006, INC Research has implemented Medidata Rave(R) in 23
studies for 14 sponsors, across Phases I - IV and in a range of categories
including CNS, pediatrics, oncology and infectious disease. Medidata Rave has
been deployed to manage trials of all sizes, from three to 1,000 participants,
and in global locations including Asia, Europe and South America. The
partnership has also yielded 15 Rave-certified study builders within INC
Research's clinical programming and data management team in the U.S. and
Europe. With these certifications, INC Research can independently build and
maintain studies in Rave and easily deploy Rave at the site level.

    Medidata Rave plays an integral role in INC Research's Trusted
Process(TM), which is its four-phased approach to proactively lead customers
through their drug and device development programs with repeatable and
measurable methodology. Rave helps ensure predictably dependable outcomes and
actionable results by increasing efficiency, decreasing time to trial
completion and maintaining clean data in the system at all times.

    "With Rave as part of our Trusted Process, we are able to launch
Rave-enabled studies quickly and efficiently and provide our customers with a
modern, flexible and single system for EDC and CDMS," said Alistair Macdonald,
senior vice president of data services for INC Research. "In addition to easy
deployment, Medidata Rave can run very complicated studies faster than any
other system available today. Moreover, sites are clearly very comfortable
working with the Medidata Rave platform, and data managers benefit from access
to data in real time with Rave's built-in reporting tools, providing insight
throughout trials."

    In addition to Rave, INC Research has also been impressed with Medidata's
services and support teams.

    "Medidata's work ethic aligns with ours - through open communication,
rapid response to our questions, and focus on customer care and management. We
appreciate that Medidata continually strives to deliver on time and exceed our
expectations. We look forward to the next phase of our relationship, which
includes influencing product development based on market trends," said
Macdonald.

    "INC Research is an industry leader in its approach to EDC, and the clear
investment in Rave knowledge transfer across its clinical and data services
organizations will help streamline clinical processes for customers
worldwide," said Tarek Sherif, CEO of Medidata Solutions. "We look forward to
continuing our relationship into 2008 and beyond."

    About INC Research

    INC Research is a therapeutically-focused contract research organization
with an unrivaled reputation for conducting global clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to INC Research for a complete range of customized Phase I through Phase
IV programs in therapeutic areas of specialty, and in innovative pediatric
trials. The company's Trusted Process(TM) methodology and therapeutic
foresight leads customers to more confident, better-informed drug and device
development decisions. INC Research is headquartered in Raleigh, North
Carolina, and now in 24 locations in 32 countries worldwide. For more
information please visit http://www.incresearch.com/.

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.




For further information:

For further information: Lois Paul & Partners Susan Lombardo,
781-782-5767 susan_lombardo@lpp.com or INC Research Kelly Foster, 619-224-1261
kellyefoster@earthlink.net

Organization Profile

MEDIDATA SOLUTIONS WORLDWIDE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890